These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8279094)

  • 21. Urinary Tamm-Horsfall protein increased after potassium citrate therapy in calcium stone formers.
    Fuselier HA; Ward DM; Lindberg JS; Allen JM; Husserl FE; Marcucci PA; Cole FE; Turnipseed J; Alam J; Kok DJ
    Urology; 1995 Jun; 45(6):942-6. PubMed ID: 7771027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of stone-forming risk by measuring crystal formation in whole urine with gel model.
    Roehrborn CG; Schneider HJ; Rugendorff EW
    Urology; 1986 Jun; 27(6):531-6. PubMed ID: 3716052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation by macromolecules of calcium oxalate crystal aggregation in stone formers.
    Wesson JA; Ganne V; Beshensky AM; Kleinman JG
    Urol Res; 2005 Jun; 33(3):206-12. PubMed ID: 15864572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria].
    Hassani MA; Hennequin C; Lacour B; Daudon M
    Prog Urol; 2005 Sep; 15(4):650-5. PubMed ID: 16459680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular modifiers reveal a mechanism of pathological crystal growth inhibition.
    Chung J; Granja I; Taylor MG; Mpourmpakis G; Asplin JR; Rimer JD
    Nature; 2016 Aug; 536(7617):446-50. PubMed ID: 27501150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stabilization of calcium oxalate suspension by urinary macromolecules, probably an efficient protection from stone formation.
    Baumann JM; Affolter B; Caprez U; Clivaz C; Glück Z; Weber R
    Urol Int; 2007; 79(3):267-72. PubMed ID: 17940361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of citrate on hydroxyapatite induced calcium oxalate crystallization and on the formation of calcium phosphate crystals.
    Berg C; Tiselius HG
    Urol Res; 1989; 17(3):167-72. PubMed ID: 2546314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronobiology of urinary citrate excretion amongst stone-formers and healthy males from north western India.
    Wangoo D; Thind SK; Gupta GS; Nath R
    Urol Res; 1991; 19(3):203-6. PubMed ID: 1887530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macromolecules inhibit calcium oxalate crystal growth and aggregation in whole human urine.
    Edyvane KA; Hibberd CM; Harnett RM; Marshall VR; Ryall RL
    Clin Chim Acta; 1987 Aug; 167(3):329-38. PubMed ID: 3621616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects.
    Robert M; Boularan AM; Delbos O; Guiter J; Descomps B
    Urol Int; 1998; 60(1):41-6. PubMed ID: 9519420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Raising urinary citrate lowers calcium oxalate and calcium phosphate crystal formation in whole urine.
    Hallson PC; Rose GA; Sulaiman S
    Urol Int; 1983; 38(3):179-81. PubMed ID: 6868215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins.
    Hess B; Nakagawa Y; Coe FL
    Am J Physiol; 1989 Jul; 257(1 Pt 2):F99-106. PubMed ID: 2750929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concentrated urine and diluted urine: the effects of citrate and magnesium on the crystallization of calcium oxalate induced in vitro by an oxalate load.
    Guerra A; Meschi T; Allegri F; Prati B; Nouvenne A; Fiaccadori E; Borghi L
    Urol Res; 2006 Dec; 34(6):359-64. PubMed ID: 16953377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhibitory effect of CG-120 on the formation, growth and aggregation of calcium oxalate crystals in vitro].
    Suzuki K; Tsugawa R
    Hinyokika Kiyo; 1988 Jun; 34(6):1073-6. PubMed ID: 3223452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low inhibition of crystal agglomeration and citrate excretion in recurrent calcium oxalate stone formers.
    Kok DJ; Papapoulos SE; Bijvoet OL
    Contrib Nephrol; 1987; 58():73-7. PubMed ID: 3691150
    [No Abstract]   [Full Text] [Related]  

  • 36. A method for studying inhibitory activity in whole urine.
    Ryall RL; Hibberd CM; Marshall VR
    Urol Res; 1985; 13(6):285-9. PubMed ID: 3006313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strong inhibition of crystal-cell attachment by pediatric urinary macromolecules: a close relationship with high urinary citrate secretion.
    Miyake O; Kakimoto K; Tsujihata M; Yoshimura K; Takahara S; Okuyama A
    Urology; 2001 Sep; 58(3):493-7. PubMed ID: 11549512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
    Ryall RL; Chauvet MC; Grover PK
    BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.
    Costa-Bauzá A; Perelló J; Isern B; Sanchis P; Grases F
    BMC Urol; 2006 Jul; 6():16. PubMed ID: 16822299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tamm-Horsfall glycoprotein--inhibitor or promoter of calcium oxalate monohydrate crystallization processes?
    Hess B
    Urol Res; 1992; 20(1):83-6. PubMed ID: 1736492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.